BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15185015)

  • 1. Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2.
    Kersten C; Delabie J; Gaudernack G; Smeland EB; Fosså A
    Cancer Immunol Immunother; 2004 Dec; 53(12):1119-26. PubMed ID: 15185015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein barr virus IgG and EBER-1 in Burkitt's lymphoma children at a referral hospital in western Kenya.
    Ndede I; Mining SK; Patel K; Wanjala FM; Tenge CN
    Pan Afr Med J; 2019; 34():206. PubMed ID: 32180880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
    Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
    Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
    Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
    J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma.
    Hartmann TB; Thiel D; Dummer R; Schadendorf D; Eichmüller S
    Br J Dermatol; 2004 Feb; 150(2):252-8. PubMed ID: 14996095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the antibody repertoire of lymphoma patients.
    Huang S; Preuss KD; Xie X; Regitz E; Pfreundschuh M
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):655-62. PubMed ID: 12439611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in three populations of Burkitt's lymphoma patients.
    Vainio E; Lenoir GM; Franklin RM
    Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
    Gaidano G; Carbone A; Pastore C; Capello D; Migliazza A; Gloghini A; Roncella S; Ferrarini M; Saglio G; Dalla-Favera R
    Blood; 1997 May; 89(10):3755-62. PubMed ID: 9160681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the human natural autoantibody repertoire using an immunoscreening approach.
    Comtesse N; Heckel D; Maldener E; Glass B; Meese E
    Clin Exp Immunol; 2000 Sep; 121(3):430-6. PubMed ID: 10971507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.
    Benjamin D; Knobloch TJ; Dayton MA
    Blood; 1992 Sep; 80(5):1289-98. PubMed ID: 1325212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis.
    Ueda K; Nakanishi T; Shimizu A; Takubo T; Matsuura N
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):65-9. PubMed ID: 18275676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
    Klein SC; Jücker M; Abts H; Tesch H
    Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma.
    Walther N; Ulrich A; Vockerodt M; von Bonin F; Klapper W; Meyer K; Eberth S; Pukrop T; Spang R; Trümper L; Kube D
    Am J Pathol; 2013 Apr; 182(4):1092-8. PubMed ID: 23375451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan.
    Chao TY; Wang TY; Lee WH
    Cancer; 1997 Jul; 80(1):121-8. PubMed ID: 9210717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to c-myc protein: elevated levels in patients with African Burkitt's lymphoma and normal Ghanians.
    LaFond RE; Eaton RB; Watt RA; Villee CA; Actor JK; Schur PH
    Autoimmunity; 1992; 13(3):215-24. PubMed ID: 1472633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas.
    Payne CM; Grogan TM; Cromey DW; Bjore CG; Kerrigan DP
    Lab Invest; 1987 Aug; 57(2):200-18. PubMed ID: 3497304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.
    Cooper CD; Lawrie CH; Liggins AP; Collins GP; Hatton CS; Pulford K; Banham AH
    PLoS One; 2011; 6(8):e23916. PubMed ID: 21887344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small noncleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. II. Pathologic and immunologic features.
    Pavlova Z; Parker JW; Taylor CR; Levine AM; Feinstein DI; Lukes RJ
    Cancer; 1987 Jun; 59(11):1892-902. PubMed ID: 2436741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.